Postoperative Adverse Events are Associated with Oncologic Recurrence Following Curative-intent Resection for Lung Cancer
- PMID: 33034720
- DOI: 10.1007/s00408-020-00395-6
Postoperative Adverse Events are Associated with Oncologic Recurrence Following Curative-intent Resection for Lung Cancer
Erratum in
-
Correction to: Postoperative Adverse Events are Associated with Oncologic Recurrence Following Curative‑intent Resection for Lung Cancer.Lung. 2020 Dec;198(6):983. doi: 10.1007/s00408-020-00409-3. Lung. 2020. PMID: 33191453
Abstract
Background: Up to 50% of patients suffer short-term postoperative adverse events (AEs) and metastatic recurrence in the long-term following curative-intent lung cancer resection. The association between AEs, particularly infectious in nature, and disease recurrence is controversial. We sought to evaluate the association of postoperative AEs on risk of developing recurrence and recurrence-free survival (RFS) following curative-intent lung resection surgery.
Methods: All lung cancer resections at a single institution (January 2008-July 2015) were included, with prospective collection of AEs using the Thoracic Morbidity & Mortality System. Cox proportional hazards models were used to estimate the effect of AEs on recurrence, with results presented as hazard ratio (HR) with 95% confidence interval (CI). An a priori, clinically driven approach to predictor variable selection was used. Kaplan-Meier curves were used examine the relationship between AE and RFS. p < 0.05 was considered statistically significant.
Results: 892 patients underwent curative-intent resection. 342 (38.3%) patients experienced an AE; 69 (7.7%) patients developed infectious AEs. 17.6% (n = 157) of patients had disease recurrence after mean follow-up of 26.5 months. Severe (Grade IV) AEs were associated with increased risk of recurrence (3.40; 95% CI 1.56-7.41) and a trend to decreased RFS. Major infectious AEs were associated with increased risk of recurrence (HR 1.71; CI 1.05-2.8) and earlier time to recurrence (no infectious AE 66 months, minor infectious 41 months, major infectious 54 months; p = 0.02).
Conclusion: For patients undergoing curative-intent lung cancer resection, postoperative AEs associated with critical illness or major infection were associated with increased risk of oncologic recurrence.
Keywords: Adverse events; Cancer recurrence; Infection; Lung cancer; Surgery.
References
-
- Mitsudomi T, Suda K, Yatabe Y (2013) Surgery for NSCLC in the era of personalized medicine. Nat Rev Clin Oncol 10(4):235–244. https://doi.org/10.1038/nrclinonc.2013.22 - DOI - PubMed
-
- Hoffman PC, Mauer AM, Vokes EE (2000) Lung cancer. Lancet 355(9202):479–485. https://doi.org/10.1016/S0140-6736(00)82038-3 - DOI - PubMed
-
- Fedor D, Johnson WR, Singhal S (2013) Local recurrence following lung cancer surgery: incidence, risk factors, and outcomes. Surg Oncol 22(3):156–161. https://doi.org/10.1016/j.suronc.2013.04.002 - DOI - PubMed - PMC
-
- Rueth NM, Parsons HM, Habermann EB, Groth SS, Virnig BA, Tuttle TM, Andrade RS, Maddaus MA, D'Cunha J (2011) The long-term impact of surgical complications after resection of stage I nonsmall cell lung cancer: a population-based survival analysis. Ann Surg 254(2):368–374. https://doi.org/10.1097/SLA.0b013e31822150fe - DOI - PubMed
-
- Andalib A, Ramana-Kumar AV, Bartlett G, Franco EL, Ferri LE (2013) Influence of postoperative infectious complications on long-term survival of lung cancer patients: a population-based cohort study. J Thoracic Oncol. https://doi.org/10.1097/JTO.0b013e3182862e7e - DOI
MeSH terms
LinkOut - more resources
Full Text Sources
Medical